Application 021216
- Type
- NDA
- Sponsor
- PARKE DAVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEURONTIN | GABAPENTIN | SOLUTION; ORAL | 250MG/5ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals,Inc. | febf610e-e088-4797-e053-6294a90a3eb5 | 2025-02-04 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 07871ab8-254b-e3c2-e063-6294a90a29ab | 2025-02-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 0919fed8-e968-b5ac-e063-6294a90afbff | 2025-02-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1ff94a9-69c4-486a-aab2-563c7ed244c8 | 2025-01-30 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 2cdbb381-88a2-5c5a-e063-6294a90a3e1e | 2025-01-29 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 2c65253d-ca49-70eb-e063-6394a90a3cd2 | 2025-01-23 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | e90d2e3d-ec86-7d1d-e053-2995a90a9167 | 2025-01-22 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | ed9cb5fe-7a2e-e0bc-e053-2a95a90a4470 | 2025-01-22 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | f40a4ee4-ae8e-769c-e053-2a95a90a344e | 2025-01-22 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Directrx | d5c9dd2c-b8ee-1406-e053-2995a90a0287 | 2025-01-21 | Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | db57e37f-0a78-4c14-8768-a28bbf9fa0da | 2025-01-21 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | DIRECT RX | a5b47f89-ed35-31de-e053-2a95a90a5554 | 2025-01-17 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | DIRECT RX | a7e45e3f-e382-32ba-e053-2a95a90a2537 | 2025-01-17 | GABAPENTIN | |
| Gabapentin | GABAPENTIN | Clinical Solutions Wholesale, LLC | 743faa18-5e7c-4fcc-9781-4157450d90c4 | 2025-01-16 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | bd5c9279-a1e3-2a59-e053-2a95a90a33a2 | 2025-01-14 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 41ce952c-6c16-4b5d-adf7-9ea114e63eb3 | 2025-01-09 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 13b87441-8fe1-40f5-8ffb-00dcd8cc90a6 | 2025-01-09 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | AvPAK | faa47fcd-2545-a946-e053-6294a90a05d2 | 2025-01-09 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 95757436-2093-41cf-a9a9-ef2f28ac096f | 2025-01-09 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 2b395a14-0f8e-7f5b-e063-6294a90ab546 | 2025-01-08 | Warnings, Adverse reactions | GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.